Experienced national law firm specializing in personal injury, auto accidents, defective products, medical malpractice, and mass tort cases.

The manager marketed Bextra for uses and dosages that were not approved by the U.S. Food and… The United States Department of Justice (U.S. DOJ) announced last week that a drug company manager has been sentenced for off-label promotion of Bextra, a violation of the Food, Drug and Cosmetic Act.

The United States Department of Justice (U.S. DOJ) announced last week that a drug company manager has been sentenced for off-label promotion of Bextra, a violation of the Food, Drug and Cosmetic Act. The manager marketed Bextra for uses and dosages that were not approved by the U.S. Food and Drug Administration (FDA). In 2005, […]

Drug maker Pfizer, Inc. led the news with two announcements this week: It took a record-breaking hit of $2.3 billion over investigations into its improper marketing of the painkiller Bextra and other medications and it is acquiring its rival, Wyeth, for $68 billion, reported Bloomberg News. Pfizer recalled Bextra in 2005 over a rare skin […]

Another study has confirmed that Vioxx and Bextra increase the risk of having a stroke. Both Bextra and Vioxx were removed from the market because of their association with heart attacks and stroke. This latest study, which looked at the stroke risk of COX2 inhibitors like Vioxx and Bextra, as well as the risk of […]

Off-label drug prescribing—using approved drugs for non-approved purposes—has long been an accepted part of the medical community. Now, a recent national survey is raising some questions regarding the safety and efficacy of such practices. Science Daily reports that a number of physicians surveyed wrongly believed some off-label drug uses were approved by the U.S. …

A new report from the Center for Economic and Policy Research (CEPR) describes the high costs associated with the mis-marketing of prescription drugs, both in dollars and in health consequences. Spending on prescription drugs has consistently been the fastest growing component of health care spending, with $373.6 billion spent on…

2006年3月9日 · Tysabri Were Suspended Due To A Fatal Side Effects. When sales of Tysabri were suspended on February 2005, many critics of the highly controversial MS drug.

Botox Maker Off-Label Marketing. Allergan Inc. is claiming that rules forbidding it from distributing information about the use of Botox wrinkle treatment.

Lamisil, a drug used to treat toenail fungus, has been linked to 16 cases of liver failure, including 11 deaths. Yet despite this risk, Lamisil is a big seller for Novartis. According to a report on Forbes.com, critics of Lamisil contend that its success is more the result of salesmanship rather than science. Though it […]